BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23721256)

  • 1. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
    Maple PA; Beard S; Parry RP; Brown KE
    Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
    Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
    Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
    von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
    J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
    Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
    J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvovirus PARV4 visualization and detection.
    Tuke PW; Parry RP; Appleton H
    J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report of human parvovirus 4 detection in Iran.
    Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
    J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human parvovirus 4 genotypes 1 and 2 in Chinese source plasma pools.
    Jia J; Zhong Y; Zhang H; Yuan D; Ma L; Wang D; Zhang J; Ma Y
    J Med Virol; 2021 Aug; 93(8):4780-4785. PubMed ID: 33200412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
    Juhl D; Görg S; Hennig H
    Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
    Chen MY; Hung CC; Lee KL
    Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
    Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
    Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
    Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
    J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the inactivation of human parvovirus 4.
    Baylis SA; Tuke PW; Miyagawa E; Blümel J
    Transfusion; 2013 Oct; 53(10 Pt 2):2585-92. PubMed ID: 24032592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
    Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
    Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
    Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
    J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens.
    Botto S; Bergallo M; Sidoti F; Terlizzi ME; Astegiano S; Ponti R; Costa C; Cavallo R
    New Microbiol; 2009 Apr; 32(2):189-92. PubMed ID: 19579698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.
    Slavov SN; Gonçalves de Noronha LA; Gonzaga FAC; Pimentel BMS; Kashima S; Haddad R
    J Med Microbiol; 2019 Apr; 68(4):622-626. PubMed ID: 30843782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
    Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
    J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus PARV4 in plasma pools of Chinese origin.
    Ma YY; Guo Y; Zhao X; Wang Z; Lv MM; Yan QP; Zhang JG
    Vox Sang; 2012 Oct; 103(3):183-5. PubMed ID: 22458565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
    Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
    PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.